MAY 15, 2018 8:10 PM PDT

Cancer Education Resources for Patients

WRITTEN BY: Mauri Brueggeman

Have you ever met patients or people who did not have a medical background? Have you heard them tell you that medicine is so hard to understand and when given a complex diagnosis like cancer, understanding what is happening seems like a whirlwind?  This test and that test…X treatment versus Y treatment…some kind of something therapy…markers mean what exactly…etc.? 

A cancer diagnosis is complex.  Even the term “cancer” has connections to other diagnostic words that can mean cancer but sound very different including neoplasia, malignancy, tumor, neoplasm, and oncogenes.  Educators and those in the medical field know this language but it is still very foreign to so many. 

The National Comprehensive Cancer Network (NCCN®) has developed patient education tools in an effort to provide basic information about individual cancers including etiology (how and where it develops), diagnosis, tests, marker details, treatment planning, treatment options, differing prognostic indicators, supportive care ideas, helpful questions to ask, things to possibly expect, helpful website links, and a list of acronyms near the end of the booklet.  There are diagrams and pictures to help in patients’ understanding.    NCCN® collaborates with other organizations to garner support for their tools and lists those collaborators in these booklets as well.

The provider and oncology staff help patients immensely with their questions and to help navigate the process and experience; however, having tools like this in the hands of patients, developed almost like a learning workbook with spaces for notes and individualization, make these an excellent tool for patients to have on hand when they aren’t with people who can define this test or that. 

The goal of these tools is to help patient’s in the shared decision-making process and to make informed decisions.  Because many of these cancer diagnoses are so complex based on numerous factors, patients don’t even realize one individual’s Acute Myeloid Leukemia (AML) diagnosis can look very different and need different treatment than the next person’s.  Some are published in a variety of languages to meet the needs of diverse patient populations.

These booklets are updated with the oldest version not updated yet being Brain Cancer/Gliomas, published in 2016.  The current list of cancer guides includes booklets (ranging in page number but approximately 50+ pages) on:

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Brain Cancer/Gliomas

Breast Cancer: Stage 0

Breast Cancer: Stage I & II

Breast Cancer: Stage III

Breast Cancer: Stage IV

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Colon Cancer

Diffuse Large B-Cell Lymphoma

Esophageal Cancer

Follicular Lymphoma

Hodgkin Lymphoma

Kidney Cancer

Lung Cancer

Lung Cancer Screening

Malignant Pleural Mesothelioma

Mantle Cell Lymphoma


Multiple Myeloma

Mycosis Fungoides

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Non-Hodgkin’s Lymphoma-Peripheral T-Cell Lymphoma

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Rectal Cancer

Soft Tissue Carcinoma

Stomach Cancer

Thyroid Cancer

Waldenström’s Macroglobulinemia (Lymphoplasmacytic Lymphoma)

Distress Supportive Care after Cancer Diagnosis

Cancer Induced Nausea & Vomiting

Adolescents and Young Adults with Cancer

Source: National Comprehensive Cancer Network


About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
NOV 21, 2019
NOV 21, 2019
Inhalable nanoparticle-immunotherapy provides new hope for lung cancer
New research published in Nature Communications details the results of a study that tested inhalable nanoparticle-immunotherapy to determine its impact on ...
NOV 22, 2019
NOV 22, 2019
The cancerous fear of circular extrachromosomal DNA
New research published in Nature suggests that ring-shaped extrachromosomal DNA (ecDNA) is particularly abundant in tumor cells and plays a malicious role ...
NOV 24, 2019
Drug Discovery & Development
NOV 24, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
DEC 02, 2019
DEC 02, 2019
Self-renewing blood stem cells give hope for blood disease treatments
New research details how activating a certain protein may be the key to getting hematopoietic stem cells (HSCs) to self-renew. The research comes from scie...
DEC 08, 2019
DEC 08, 2019
Why do colder, wetter climates have a higher prevalence of cancer?
You might want to sit down, because this news may come as a surprise: researchers have found an association between cold, wet climates and increased cancer...
DEC 09, 2019
DEC 09, 2019
Hair dyes associated with increased risk of breast cancer
Research recently published in the International Journal of Cancer suggests that certain hair dyes and chemical relaxants are associated with breast cancer...
Loading Comments...